Necrotising vasculitis associated with captopril therapy. 1987

J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018366 Vasculitis, Leukocytoclastic, Cutaneous Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases. Angiitis, Hypersensitivity,Cutaneous Leukocytoclastic Vasculitis,Hypersensitivity Angiitis,Hypersensitivity Vasculitis,Vasculitis, Hypersensitivity,Allergic Cutaneous Angiitis,Allergic Cutaneous Vasculitis,Angiitis, Allergic Cutaneous,Cutaneous Allergic Vasculitis,Cutaneous Leukocytoclastic Angiitis,Vasculitis, Allergic Cutaneous,Allergic Cutaneous Angiitides,Allergic Cutaneous Vasculitides,Allergic Vasculitides, Cutaneous,Allergic Vasculitis, Cutaneous,Angiitides, Allergic Cutaneous,Angiitides, Cutaneous Leukocytoclastic,Angiitides, Hypersensitivity,Angiitis, Cutaneous Leukocytoclastic,Cutaneous Allergic Vasculitides,Cutaneous Angiitides, Allergic,Cutaneous Angiitis, Allergic,Cutaneous Leukocytoclastic Angiitides,Cutaneous Leukocytoclastic Vasculitides,Cutaneous Vasculitides, Allergic,Cutaneous Vasculitis, Allergic,Hypersensitivity Angiitides,Hypersensitivity Vasculitides,Leukocytoclastic Angiitides, Cutaneous,Leukocytoclastic Angiitis, Cutaneous,Leukocytoclastic Vasculitides, Cutaneous,Leukocytoclastic Vasculitis, Cutaneous,Vasculitides, Allergic Cutaneous,Vasculitides, Cutaneous Allergic,Vasculitides, Cutaneous Leukocytoclastic,Vasculitides, Hypersensitivity,Vasculitis, Cutaneous Allergic,Vasculitis, Cutaneous Leukocytoclastic

Related Publications

J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
December 1990, British journal of urology,
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
July 1985, Lancet (London, England),
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
September 1968, The British journal of dermatology,
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
January 2001, Clinical medicine (London, England),
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
May 1981, British medical journal (Clinical research ed.),
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
April 1981, British medical journal (Clinical research ed.),
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
October 1989, Australian and New Zealand journal of medicine,
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
September 1988, Annals of internal medicine,
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
June 2009, European journal of clinical pharmacology,
J Laaban, and J P Marie, and D Wallach, and D Blanchard, and M Lafay, and F Gruffaz
April 1983, The American journal of medicine,
Copied contents to your clipboard!